IPG Photonics (IPGP) Q1 2025 earnings summary

Executive summary

• Q1 2025 revenue was $227.8 million, down 10% year-over-year but above the midpoint of guidance, driven by growth in medical, micromachining, and advanced applications, while cutting and welding sales declined.

• Book-to-bill ratio was above one and the highest in over two years, indicating strong bookings momentum.

• Emerging growth products represented 51% of total revenue, with strong performance in AMB lasers, micromachining, and handheld welding.

• Adjusted EBITDA was $32.7 million and adjusted EPS was $0.31, both at the top end of guidance.

• CleanLaser acquisition and new product launches contributed to growth in cleaning and additive manufacturing.

Financial highlights

• GAAP gross margin improved to 39.4%, up 70 basis points year-over-year; adjusted gross margin was 40%.

• Net income dropped 84% year-over-year to $3.8 million ($0.09 per diluted share); adjusted EPS was $0.31.

• Operating income was $1.8 million, down 91% year-over-year; adjusted EBITDA was $32.7 million, down 19%.

• Cash and equivalents totaled $927 million, including $363 million in cash and $564 million in short-term investments as of March 31, 2025; no debt.

• Cash flow from operations was $13 million; capital expenditures were $25 million.

Outlook and guidance

• Q2 2025 revenue expected between $210 million and $240 million, with guidance $15 million lower due to tariff-related shipment delays.

• Adjusted gross margin guidance is 36%-38%, with a 150-200 basis point tariff impact; operating expenses expected at $86-$88 million.

• Adjusted EPS expected between -$0.05 and $0.25; adjusted EBITDA between $16 million and $31 million.

• Bookings momentum and global manufacturing footprint expected to mitigate tariff impacts.

• Operating expenses to remain elevated through 2025 due to ongoing investments in growth and organizational strength.